with the device. 10 Trials have suggested that stent retrievers are safer and more effective than earlier thrombectomy devices, with fewer procedural complications and better long-term outcomes. 13, 17 The availability of multiple mechanical thrombectomy devices, each with very different approaches to clot removal, mandates further investigation into their safety and clinical efficacy. Therefore, we reviewed our multiphysician, single-center experience, analyzing angiographic and clinical outcomes of treatment with 3 FDAapproved mechanical thrombectomy devices (MERCI, Penumbra, Solitaire-FR) during the standard 3-to 8-hour endovascular therapy window for acute ischemic stroke. Our null hypothesis for this study was that there would be no difference in angiographic and clinical outcomes between cases in which stent retrievers (Solitaire-FR) were used and cases in which earlier-generation thrombectomy devices (MERCI and Penumbra) were used.
Methods

Data Collection
A retrospective analysis of consecutive acute ischemic stroke case in which patients were treated with intraarterial mechanical thrombectomy (3-to 8-hour window) was performed to examine angiographic and clinical outcomes. It should be noted that some of these cases have been reported in the IMS-III (Interventional Management of Stroke III) trial, as our institution was a participating site. The thrombectomy device chosen for each case was largely reflective of the date, with the MERCI retriever being used in earlier cases and the Solitaire-FR device being used in the most recent cases. There was overlap of Penumbra cases into the MERCI and Solitaire-FR eras, and the decision to use the Penumbra device was based on device availability at the time and the preference of the interventionalist. This review was performed with the approval of our institutional review board. Extracted data included: patient age, medical comorbidities, NIH Stroke Scale (NIHSS) score at admission, intravenous (IV) administration of recombinant tissue plasminogen activator (rt-PA), clot location, ASPECTS (Alberta Stroke Program Early CT Score), 5 method of intraarterial thrombectomy, time from symptom onset until revascularization, and complications related to intraarterial therapy (procedural complications included intraparenchymal or subarachnoid hemorrhage; periprocedural complications included hemorrhagic transformation as evidenced on subsequent CT scans). An independent observer reviewed the posttreatment angiogram and assigned a "thrombolysis in cerebral infarction" (TICI) score.
14 Medical records were reviewed to extract the modified Rankin Scale (mRS) score assigned to each patient at the time of discharge by the primary clinical team. A possible "learning curve" was considered in order to evaluate whether the interventionalists became more skilled at revascularization as they obtained more experience with each device. The case series for each device was dichotomized based on time, and an "experience" variable was assigned to the latter half of the cases for each device.
Statistical Analysis
Data were analyzed using SPSS version 17 (IBM Corp.). Chi-square tests and Fisher exact tests were used to make categorical comparisons as appropriate. A Kruskal-Wallis test was used to make comparisons between continuous variables. In order to account for patient variation in the dichotomous outcome measures (functional independence [mRS score ≤ 2] and successful reperfusion, [TICI score 2b or 3]), generalized linear multivariate models (stepwise binary logistic regression) were used to compare and make inferences about device effects. This allows for comparison while adjusting for confounding variables. Backward stepwise selection was performed with entry at a probability of 0.05 and removal at 0.10. The Hosmer-Lemeshow goodness-of-fit statistic and Nagelkerke R 2 are reported for each model. Univariate analysis was performed to select the confounding variables with the greatest significance (p values not to exceed 0.10) to be added to the regression models. A minimum of 6 outcome events per predictor variable was required. 20 Continuous independent variables added to the model were verified to be linearly related to the logit of the dependent variable. Cases with missing variables were excluded from analysis. Odds ratios and their 95% confidence intervals are reported. Two-sided p values less than 0.05 were considered statistically significant for all analyses.
Results
Three neurointerventionalists treated 102 acute ischemic stroke patients with mechanical thrombectomy from 2007 to 2013 (Table 1 ). There were no significant differences in the baseline neurological status and comorbidities for patients treated with each thrombectomy device. Patients treated with the MERCI device had a significantly greater rate of middle cerebral artery (MCA) occlusions than those treated with Solitaire-FR or Penumbra (p = 0.005).
Thrombectomy device had a significant effect on functional independence (mRS score ≤ 2) at discharge from the hospital (p = 0.040). Solitaire-FR treatment resulted in significantly more patients being discharged with functional independence in comparison with patients treated with MERCI (p = 0.016). Solitaire-FR treatment also resulted in a 17% greater rate of functional independence than Penumbra treatment, although the difference was not statistically significant (p = 0.139). A multivariate model was constructed that was statistically significant (χ 2 = 21.583, p < 0.001, Hosmer-Lemeshow goodness-offit statistic = 0.568). The model explained 33% (Nagelkerke R 2 ) of the variance in functional independence and 4 cases were excluded due to missing data points. Of the 3 predictor variables entered into the model, only 2 were statistically significant-use of the Solitaire-FR device and the admission NIHSS (Table 2) . Solitaire-FR improved the odds of good clinical outcome by more than 6-fold.
In univariate analysis, device had a significant effect on successful reperfusion (p = 0.025) ( Table 1) . Solitaire-FR resulted in a significantly greater incidence of suc-cessful reperfusion in comparison with patients treated with MERCI (p = 0.008), but not with respect to Penumbra (p = 0.153). A multivariate model was constructed that was statistically significant (χ 2 = 13.331, p = 0.001, Hosmer-Lemeshow goodness-of-fit statistic = 0.873). The model explained 17% (Nagelkerke R 2 ) of the variance in successful reperfusion, and there were no excluded cases. Of the 6 predictor variables entered into the model, only 2 were statistically significant-use of the Solitaire-FR device and thrombus identified in the MCA (Table 2) . Solitaire-FR increased the odds of successful reperfusion (TICI score of 2b or 3) by more than 3-fold.
When Solitaire-FR was used for mechanical thrombectomy, patients were treated with adjunctive pharmacological thrombolysis in only 32% of cases compared with rates exceeding 80% for cases in which the MER-CI and Penumbra devices were used (p < 0.001). There were no significant differences in mortality or procedural hemorrhage between devices (p = 0.108 and p = 0.180, respectively). Experience with the device (device experience) was not observed to significantly affect clinical or radiographic outcomes (Table 3) .
Discussion
It was the intent of our analysis to compare the safety and efficacy of the various intraarterial device treatment modalities in a real-life setting during the accepted 3-to 8-hour endovascular treatment window. For this study, we hypothesized that angiographic and clinical outcomes would be independent of the type of endovascular thrombectomy modality and mechanical device. Therefore, we reviewed our acute stroke data and compared the latest FDA-approved mechanical thrombectomy device (Solitaire-FR) with the previous generations of thrombectomy devices (MERCI and Penumbra). All patients were sent to interventional radiology for revascularization mainly for one of 4 reasons: 1) failure of IV rt-PA administered within the 3-hour window, 2) presentation beyond the 3-hour window for IV rt-PA, 3) randomization to the IV rt-PA plus intraarterial therapy arm of the IMS-III trial (our institution was a participating site), or 4) presented with a "wake-up stroke" with a perfusion-diffusion mismatch on MRI. At our institution, we do not routinely use CT or MR perfusion to identify candidates for intraarterial ther- apy; rather, any patient with a known time of symptom onset who is not a candidate for IV rtPA, or who is no longer within the treatment window for IV rtPA, would be treated with endovascular therapy. Computed tomography perfusion and MR perfusion studies are reserved for patients with "wake-up" strokes and those without a known time of symptom onset. Solitaire-FR was associated with significantly improved odds of successful reperfusion (TICI score ≥ 2b) and patients being discharged as functionally independent (mRS score ≤ 2), in comparison with the older generations of thrombectomy devices (Penumbra and MERCI). These results support recent findings in the literature demonstrating that stent retrievers are superior to previous technology. Ribo et al. concluded that use of stent retrievers, including Solitaire-FR and Trevo, doubles the odds of a favorable outcome (defined as mRS score ≤ 2 at 3 months) in comparison with treatment with the MERCI device or intraarterial thrombolysis. 16 Broussalis et al. examined 122 patients treated with mechanical thrombectomy at their institution and documented an 82% rate of successful reperfusion, similarly defined as TICI 2b or 3, when the patient was treated with a stent retriever. 7 This rate was significantly higher than the average rate of 62% for cases treated with MERCI. The authors also found better clinical outcomes and a lower complication rate for cases treated with stent retrievers. Agrawal et al. examined reperfusion rates in a smaller subset of patients (n = 20) who were treated with mechanical thrombectomy and also found a significant improvement for patients treated with Solitaire-FR in comparison with those treated with MERCI and Penumbra.
1
The literature also includes 2 recently published randomized trials that examined stent retrievers in comparison with the MERCI retriever. 13, 17 Nogueira et al. randomized 178 patients at 27 sites. 13 The primary efficacy endpoint, TICI score ≥ 2a, was achieved in 86% of patients in the Trevo group in comparison with only 60% of the MERCI group with no difference in adverse events. Saver et al. randomized 113 patients at 18 sites. 17 The study concluded that Solitaire-FR achieved substantially better angiographic, safety, and clinical outcomes than did the MERCI retrieval system. In the present study, we also evaluated the effect of experience with the devices, and we found no significant trend showing better clinical outcomes or revascularization over time (for any of the devices), which would have introduced bias into the evaluation of the devices. Ribo et al. needed significantly less time to achieve recanalization when using a stent retriever than with the MERCI retrieval system (88 minutes vs 128 minutes, respectively). 16 In our analysis, the average intraarterial time until final recanalization for Solitaire-FR was 66 minutes. Although this time was lower than that reported by Ribo et al., it was not significantly reduced in comparison with our time with the MERCI retriever, 72 minutes. The abbreviated time needed to achieve recanalization, ease of use, and the greater amount of reperfusion achieved with Solitaire-FR are likely contributors to the improved intervention outcomes. It is also worth noting that intraarterial pharmacological agents were not used in 62% of the Solitaire-FR cases as opposed to only 13% of the MERCI and Penumbra cases, suggesting that the improved TICI scores noted in this category were not largely assisted by pharmacological means. This may be especially important in the subpopulation of stroke patients with contraindications to thrombolysis and may also be important in preventing additional hemorrhagic complications induced by thrombolysis.
In our study, MCA occlusions were the least likely to be recanalized following thrombectomy. This may reflect a tendency for these clots to be more common overall in our patient population and also represent carotid-T occlusions with partial recanalization of the internal carotid artery and residual clot in the MCA that is difficult to retrieve. 4 The high incidence of these cases in the MERCI group may result in a bias. However, the multivariate analysis controlled for location and still found Solitaire-FR to increase the odds of successful reperfusion. This is in agreement with both randomized clinical trials comparing stent retrievers and the MERCI retrieval system that demonstrated improved recanalization rates for stent retrievers. 13, 17 Future studies evaluating the efficacy and safety profile of mechanical thrombectomy devices for acute ischemic stroke, particularly within the first 3 hours after symptom onset, need to include stent retriever devices. MR-RESCUE (Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy), SYNTHESIS Expansion (Synthesis Expansion: A Randomized Controlled Trial on Intra-Arterial Versus Intravenous Thrombolysis in Acute Ischemic Stroke), and IMS-III are such trials that predated stent retrievers and failed to demonstrate a significant benefit of mechanical thrombectomy. 6, 8, 11, 12, 21 Further studies with newly designed retrievable stent technology may demonstrate very different results for thrombectomy within the 3-hour window.
The limitations of this study include its retrospective design, both in patient assessment to treatment modality, and the retrospective assessment of mRS score from the chart review. The small sample size also limits the conclusions that can be drawn regarding any nonsignificant findings due to low statistical power. A large multicenter randomized approach is critical to provide conclusive evidence regarding the benefit stent retrievers may provide to patients with acute ischemic stroke.
Conclusions
Clinical outcome after endovascular treatment of acute ischemic stroke is multifactorial. The stent retriever Solitaire-FR resulted in significantly improved odds of complete reperfusion and functional independence at discharge. Solitaire-FR should be compared with other similar stent retrievers on the market to examine angiographic efficacy and clinical outcomes among this family of devices. Furthermore, development of well-designed studies to evaluate potential benefits of mechanical thrombectomy within the 3-hour acute stroke window using stent retriever devices is still pending.
